Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer

Andrew Rh Shepherd, Emily Shepherd, Nicholas R. Brook

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of intravesically administered Bacillus Calmette-Guérin (BCG) plus interferon(IFN)-alpha(α) compared with BCG alone for treating non-muscle-invasive bladder cancer (NMIBC).

Original languageEnglish
Article numberCD012112
JournalCochrane Database of Systematic Reviews
Issue number3
Publication statusPublished or Issued - 5 Mar 2016
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this